CAM
UTHR icon

CG Asset Management’s United Therapeutics UTHR Stock Holding History

CG Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,835
Closed -$427K – 128
2016
Q1 		$427K Sell
3,835
-1,700
-31% -$215K 0.17% 95
2015
Q4 		$867K Sell
5,535
-10,400
-65% -$1.51M 0.34% 71
2015
Q3 		$2.09M Sell
15,935
-6,160
-28% -$988K 0.88% 41
2015
Q2 		$3.84M Buy
22,095
+1,100
+5% +$198K 1.47% 21
2015
Q1 		$3.62M Buy
20,995
+9,700
+86% +$1.48M 1.41% 23
2014
Q4 		$1.46M Buy
11,295
+4,945
+78% +$637K 0.58% 55
2014
Q3 		$817K Buy
6,350
+900
+17% +$92.8K 0.34% 78
2014
Q2 		$482K Sell
5,450
-14,025
-72% -$1.35M 0.2% 94
2014
Q1 		$1.83M Sell
19,475
-7,275
-27% -$744K 0.82% 50
2013
Q4 		$3.02M Buy
+26,750
New +$2.41M 1.38% 26

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CG Asset Management's UTHR Position: Q2 2016 in Review

CG Asset Management sold out of United Therapeutics (UTHR) in Q2 2016, closing a stake of 3,835 shares — an estimated $427K sold.

CG Asset Management first reported a position in UTHR in Q4 2013 and held it in 10 quarters. The position peaked at $3.84M in Q2 2015. 384 funds tracked by Wall St. Rank hold UTHR as of Q2 2016.

  • CG Asset Management reported no remaining United Therapeutics position as of Q2 2016 after selling out during the quarter.
  • CG Asset Management sold 3,835 United Therapeutics shares in Q2 2016, an estimated $427K.
  • CG Asset Management first reported a position in United Therapeutics in Q4 2013 and held it in 10 quarters.
  • CG Asset Management's United Therapeutics position peaked at $3.84M in Q2 2015.
  • 384 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2016.

Based on CG Asset Management's 13F filing for Q2 2016, filed 27 Jul 2016.